Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure: The etude cas-temoin de l'infarctus du myocarde (ECTIM) study

Hypertension

Volumn 28, Issue 5, 1996, Pages 881-887

  Cambien, François ^a   Ricard, Sylvain ^a   Troesch, Alain ^b   Mallet, Christine ^a   Générénaz, Laurence ^b   Evans, Alun ^c   Arveiler, Dominique ^d   Luc, Gérald ^d   Ruidavets, Jean Bernard ^d   Poirier, Odette ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Belfast MONICA Project   (United Kingdom)

^d NONE

Author keywords

myocardial infarction; polymorphism, genetic; transforming growth factors

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CLINICAL FEATURE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 10344243008     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.5.881     Document Type: Article

References (38)

1. Dickson K, Philip A, Warshawsky H, O'Connor-McCourt M, Bergeron JJM. Specific binding of endocrine transforming growth factor-β1 to vascular endothelium. J Clin Invest. 1995;95:2539-2554.
2. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β1. Science. 1988; 242:97-99.
3. Gamble JR, Vadas MA. Endothelial adhesiveness for human T-lymphocytes is inhibited by transforming growth factor-β1. J Immunol. 1991;148:1149-1154.
4. Gamble JR, Khew-Goodall Y, Vadas MA. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J Immunol. 1993;150:4494-4503.
5. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
6. Brown SL, Lundgren CH, Nordt T, Fujii S. Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. Cardiovasc Res. 1994;28:1815-1820.
7. Grainger D, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nature Medicine. 1995;1:74-79.
8. Agrotis A, Saltis J, Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 1994;23:593-599.
9. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial TGF β1 transcription and production: modulation by potassium channel blockade. J Clin Invest. 1995;95:1363-1369.
10. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta A, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83:4167-4171.
11. Takahashi N, Calderone A, Izzo NJ, Mäki TM, Marsh JD, Colucci WS. Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocytes. J Clin Invest. 1994;94: 1470-1476.
12. Derinck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor β complementary DNA sequence and expression in normal and transformed cells. Nature. 1985;316:701-705.
13. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetière P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for CHD, the Ectim Study. Arterioscler Thromb. 1992;12:701-707.
14. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans AE, Nicaud V, Cambien F. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction, The ECTIM Study. J Hypertens. 1995;13:311-317.
15. Scarabin PY, Barra L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β fibrinogen gene in relation to plasma fibrinogen concentrations and risk of myocardial infarction. Arterioscler Thromb. 1993;13: 886-891.
16. Ye S, Green FR, Henney AM, Dawson SJ, Humphries SE, Scarabin PY, Evans A, Cambou JP, Arveiler D, Bara L, Cambien F. Genetic variation in the promoter of the plasminogen activator inhibitor type-1 (PAI-1) gene in relation to plasma PAI-1 activity and risk of myocardial infarction: The ECTIM Study. Thromb Haemost. 1995; 74:837-841.
17. Saiki RK, Gefland DH, Stoffel S, Scahrf SJ, Higuchi R, Horn GT, Mullis KB, Herlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polyraerase. Science. 1988;239:487-491.
18. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879.
19. Derynck R, Rhee L, Chen EY, Van Tilburg A. Intron-exon structure of the transforming growth factor β precursor gene. Nucleic Acids Res. 1987;15:3188-3189.
20. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem. 1989;264:402-408.
21. Hayashi K. PCR-SSCP: a single sensitive method for detection of mutations in the genomic DNA. PCR. 1991;1:34-38.
22. Sanger F, Nicklen S, Coulson R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA. 1977;74:5463-5467.
23. Saiki RK. Genetic analysis of enzymatically amplified β globin and HLA-DQa genomic DNA with allele specific oligonucleotide probes. Nature. 1987;324:163-166.
24. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
25. Nei M. Molecular Evolutionary Genetics. New York, NY: Columbia University Press: 1987.
26. MacLean CJ, Morton NE. Estimation of myriad haplotype frequencies. Genet Epidemiol. 1985;2:263-272.
27. Kojima S, Harpel PC, Rifkin DB. Lipoprotein(a) inhibits the generation of transforming growth factor-beta: an endogenous inhibitor of smooth muscle cell migration. J Cell Biol. 1991;113:1439-1445.
28. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature. 1994;370:460-462.
29. Randall LL, Hardy SJS. Unity in function in the absence of consensus in sequence: role of leader peptides in export. Science. 1989;243: 1156-1159.
30. Benson SA, Hall MN, Silhavy TJ. Genetic analysis of protein export in Escherichia coli K12. Annu Rev Biochem. 1985;54:101-134.
31. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanisms of activation of transforming growth factor β1 by plasmin. J Cell Biol. 1990;110:1361-1367.
32. Gamble JR, Bradley S, Noack L, Vadas MA. TGF-β and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:949-955.
33. Matsumura Y, Murata S, Takada K, Takaoka M, Morimoto S. Involvement of transforming growth factor-β1 for platelet-induced stimulation of endothelin-1 production. Clin Exp Pharmacol Physiol. 1994;21:991-996.
34. Cristiani C, Volpi D, Landonio A, Bertolero F. Endothelin-1-selective binding sites are downregulated by transforming growth factor-beta and upregulated by basic fibroblast growth factor in a vascular smooth muscle-derived cell line. J Cardiovasc Pharmacol. 1994;23:988-994.
35. Kenny D, Coughlan MG, Pagel PS, Kampine JP, Warltier DC. Transforming growth factor beta 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion. Am Heart J. 1994;127:1456-1461.
36. Lefer AM, Tsao P, Aoki N, Palladiro MA. Mediation of cardioprotection by transforming growth factor β. Science. 1990;249:61-64.
37. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by Lp(a). Science. 1993;260:1655-1657.
38. Border WA, Noble NA. Transforming growth factor β and tissue fibrosis. N Engl J Med. 1994;331:1286-1292.